The Vanguard Study: Testing a New Way to Screen for Cancer
NCT06995898
Adenocarcinoma, Adnexal Diseases
Pleasanton, California, United States
View Trial DetailsNCT Number: NCT07309991
This study aims to determine whether postoperative hypoxia (arterial partial pressure of oxygen (PaO₂)<80 mmHg) is an independent risk factor for anastomotic leakage after esophagectomy. The investigators conducted a retrospective analysis of cases from their center over the past five years, stratifying patients into Low Pa0₂ Group and Normal Pa0₂ Group based on postoperative oxygen levels and comparing the incidence of anastomotic leakage between the groups. The goal is to establish whether hypoxia is a causative risk factor and whether correcting it can reduce the risk of anastomotic leakage.
Interested in participating?
Request Info18 year–80 year
All sexes
Observational
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
This retrospective study included all patients who underwent radical esophagectomy at our center over the past five years. After screening based on inclusion and exclusion criteria, PaO₂ levels within the first postoperative week were recorded (the lowest value was used if multiple measurements were taken on the same day), along with whether the condition improved after corrective interventions, patients were accordingly divided into Low Pa0₂ Group (at least one recorded instance of PaO₂ <80 mmHg) and Normal Pa0₂ Group. Anastomotic leakage was diagnosed based on barium swallow, endoscopy, chest-abdominal CT, or typical clinical signs. By comparing the incidence of anastomotic leakage between the two groups, the relationship between postoperative PaO₂ and anastomotic leakage was analyzed, with further investigation into whether postoperative hypoxemia constitutes an independent and modifiable risk factor.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From the date of surgery to 30 days postoperatively
Anastomotic leak was confirmed by either barium swallow study, CT scan, or endoscopy, or was clinically considered in cases with obvious salivary secretion from the cervical anastomosis.
The esophageal anastomotic leakage rate was calculated as (the number of patients with a confirmed anastomotic leakage / the total number of patients who underwent esophagectomy) × 100%.
Contact information is provided by the study sponsor or research team.
Hong Yang, M.D.
CONTACT
Yizhang Chen, M.D. candidate
CONTACT
Sun Yat-sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06995898
Adenocarcinoma, Adnexal Diseases
Pleasanton, California, United States
View Trial DetailsNCT07283939
Ampulla of Vater Carcinoma, Appendiceal Neoplasms
Fairbanks, Alaska, United States
View Trial DetailsNCT00991094
Breast Carcinoma, Breast Diseases
Houston, Texas, United States
View Trial DetailsNCT06265285
Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma
Jacksonville, Florida, United States
View Trial Details